Pharmacovigilance and tuberculosis: applying the lessons of thioacetazone

Bull World Health Organ. 2014 Dec 1;92(12):918-9. doi: 10.2471/BLT.14.142570. Epub 2014 Oct 7.

Authors

Dennis Falzon¹, Geraldine Hill², Shanthi N Pal³, Wimon Suwankesawong⁴, Ernesto Jaramillo¹

Affiliations

¹ Global TB Programme, World Health Organization, avenue Appia 20, 1211 Geneva 27, Switzerland .
² Uppsala Monitoring Centre, Uppsala, Sweden .
³ Essential Medicines and Health Products, World Health Organization, Geneva, Switzerland .
⁴ National Pharmacovigilance Centre, Bangkok, Thailand .

No abstract available

MeSH terms

Adverse Drug Reaction Reporting Systems*
Antitubercular Agents / adverse effects*
Antitubercular Agents / pharmacokinetics
Drug Resistance, Multiple, Bacterial / drug effects
Global Health
Humans
Pharmacovigilance
Thioacetazone / adverse effects*
Thioacetazone / pharmacology
Tuberculosis / drug therapy*
World Health Organization

Substances

Antitubercular Agents
Thioacetazone

Grants and funding

001/WHO_/World Health Organization/International